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Available online 3 April 2013Abstract The efficient production of human neocortical neurons from human embryonic stem cells (hESC) is the primary
requirement for studying early stages of human cortical development. We used hESC to obtain radial glial cells (hESC-RG) and
then compared them with RG cells isolated from human fetal forebrain. Fate of hESC-RG cells critically depends on intrinsic
and extrinsic factors. The expression of Pax6 (intrinsic factor) has a similar neurogenic effect on hESC-RG differentiation as
reported for human fetal RG cells. Factors from the microenvironment also play a significant role in determining hESC-RG cell
fate. In contrast to control cultures, wherein hESC-RG generate mainly astroglia and far fewer neurons, in co-cultures with
human fetal forebrain cells, the reverse was found to be true. This neurogenic effect was partly due to soluble factors from
human fetal brain cultures. The detected shift towards neurogenesis has significance for developing future efficient
neuro-differentiation protocols. Importantly, we established that hESC-RG cells are similar in many respects to human fetal RG
cells, including their proliferative capacity, neurogenic potential, and ability to generate various cortical neuronal sub-types.
Unlike fetal RG cells, the hESC-RG cells are readily available and can be standardized, features that have considerable
practical advantages in research and clinics.
Published by Elsevier B.V.differentiated cells including motoneurons (Li et al., 2005),Introduction
Human embryonic stem cells (hESC) provide an ideal system
for understanding brain development under both healthy and
diseased conditions. They represent a potentially unlimited
source of transplantable cells for the therapy of neurodegen-
erative disorders, and provide an alternative to drug screening
and toxicology assays. Numerous studies have investigated the
neurogenic potential of embryonic stem cells and demon-
strated that they could be the source of a wide variety of⁎ Corresponding author at: Department of Neuroscience, University
of Connecticut Health Center, 263 Farmington Ave., Farmington, CT
06030, USA. Fax: +1 860 679 8766.
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http://dx.doi.org/10.1016/j.scr.2013.03.004dopaminergic and serotoninergic neurons (Belinsky et al.,
2011; Yan et al., 2005), glutaminergic and GABAergic neurons
(Li et al., 2009), peripheral neurons (Mizuseki et al., 2003),
astrocytes and oligodendrocytes (Brustle et al., 1999), and
radial glial (RG) cells (Nat et al., 2007).
Radial glial cells are formed from neuroepithelial cells in
the early stages of the nervous system development. Along
with neuroepithelial markers such as the intermediate fila-
ment protein nestin (Hartfuss et al., 2001; Pollard et al., 2006)
and stem cell markers, such as transcription factors Sox2 (Suh
et al., 2007) and Pax6 (Bibel et al., 2004; Götz et al., 1998),
they also express astroglia markers such as astrocyte-specific
glutamate aspartate transporter (GLAST), brain lipid-binding
protein (BLBP), vimentin, RC2, and glial fibrillary acidic protein
(GFAP) (Campbell and Gotz, 2002; Noctor et al., 2001). It is the
588 G. Reinchisi et al.astroglial features that distinguish RG cells from neuroepithelial
cells. A surface marker Lex1/CD15, an extracellular matrix-
associated carbohydrate, is expressed both in mouse embryonic
stem cells (Kim and Morshead, 2003; Capela and Temple, 2006)
and human fetal radial glia (Mo et al., 2007). In the present
study we identified RG cells in vivo and in vitro by astroglial
progenitor/stem markers combined with their typical bipolar
shape.
RG cells have been generated from a variety of different
sources of embryonic and adult brains, and embryonic stem
cells (Conti et al., 2005; Liour and Yu, 2003; Bibel et al., 2004;
Malatesta et al., 2000). In addition to isolating RG cells from
human fetal tissue (Mo et al., 2007), it has recently been
shown that RG cells can be generated from hESC (Nat et al.,
2007). We have used the abbreviation hESC-RG to refer to
radial glial cells generated in this manner.
Originally, RG cells were demonstrated to be important in
guiding radial migration of neurons (Bentivoglio and Mazzarello,
1999; Rakic, 2003). However, it has been well-documented
recently that RG cells are also multipotent progenitor/stem
cells, and that they account for the majority of neurogenesis in
the developing and postnatal rodent brain (Malatesta et al.,
2000; Noctor et al., 2001; Miyata et al., 2001; Götz andHuttner,
2005). In the human brain RG cells express GFAP in early stages
of the emerging cerebral cortex (Zecevic, 2004; Howard et al.,
2006, 2008), in contrast to rodents where this happens much
later in corticogenesis. Human RG cells serve as multipotent
neural progenitors generating both neurons and glial cells (Mo et
al., 2007; Mo and Zecevic, 2008, 2009; Hansen et al., 2010).
Transcription factor Pax6 (Pair Box 6) plays a significant role in
neurogenetic capabilities of human fetal radial glial cells (Mo
and Zecevic, 2008).
The objective of the present investigation was to compare
RG cells in the human fetal forebrain (Mo et al., 2007; Mo and
Zecevic, 2008) with hESC-RG cells with the idea that these
cells can become an unlimited source of neurons available for
research.
Our findings suggest that hESC-RG share many antigen
characteristics, proliferative capacity, and differentiation
pattern with human fetal RG cells and thus are suitable for
further research on human brain development.Material and methods
Human ESC culture
Human ES cell line H9 (Stem Cell Core, UCONN) and H9 stably
transfected with EGFP (enhanced green fluorescent protein)
under a constitutively active CAG promoter, a gift from Dr. Cai,
University of Connecticut Health Center, passages 30–45,
were passaged weekly on a feeder layer of irradiated mouse
embryonic fibroblasts (MEFs) as previously described (Zhang et
al., 2001). The culturemediumconsisted of Dulbecco'smodified
Eagle's medium (DMEM)/F12 (GIBCO-BRL) with 20% knockout
serum replacement, 1 mM glutamine, 1% nonessential amino
acid (all from GIBCO-BRL), 0.1 mM β-mercaptoethanol, and
4 ng/ml bFGF2 (basic fibroblast growth factor; PeproTech, Lake
Placid, NY).
The colonies were differentiated into neural cells using
a protocol previously described by Nat et al. (2007). For
immunostaining, flow cytometry and magnetic-activatedcell separation, the floating aggregates were treated with
Accutase™ (Chemicon) in 37 °C incubator for ~10 min to
obtain single cells.Co-culture experiments
The hESC-RG expressing EGFP (3 × 103 cells/well) were plated
over mixed cell cultures (1 × 105 cells/1.7 cm2 well of a 4-well
chamber slide, BD Falcon) from the human fetal forebrain (17 to
20 gestational weeks—gw) containing both telencephalon and
diencephalon, obtained from the Brain Bank repositories.
Human tissue has been collected following rules of appropriate
institutions, withwritten consent, from unidentifiable subjects.
The cultures were maintained and processed as previously
described (Howard et al., 2006; Zecevic, 2004; Mo et al., 2007).
To study the effects of secreted factors from human fetal cells,
conditioned medium (CM) was collected every 2 days from
these primary cultures, filtered through a 0.22-μm membrane
and stored at −20 °C. This medium was added in the same way
as commercially available medium was added to control
cultures.Immunostaining
Cell cultures were fixed with 4% paraformaldehyde and
immunostaining was performed as previously described (Mo
and Zecevic, 2008). Primary antibodies against the following
proteins were diluted in the blocking solution and applied
overnight: vimentin 1:200, GABA 1:300, andMAP2 1:200 (Sigma,
Saint Louis, MO), GFAP 1:2000 and BrdU (Bromo-deoxyuridine)
1:100 (Dako, Denmark), calretinin 1:500 (Millipore, Temecula,
CA), doublecortin 1:200 (Santa Cruz, CA), β-III-tubulin 1:2000
and Pax6 1:1000 (Covance, CA), Ki67 1:25 (Beckman Coulter,
France), phosphorylated vimentin 4A4 1:500 (MBL), tyrosine
hydroxylase 1:1000 (Pel-Freez Biological, Rogers, Arkansas),
SMI32 1:1000 (Sternberger Monoclonals Inc., Baltimore,
Maryland), SV2 1:500 (Developmental Studies Hybridoma
Bank, IA), PDGFRα 1:500 (Pharmingen, San Diego, CA), GFP
1:500 and Foxg1 1:1000 (Abcam, Cambridge, MA), LeX/CD15
1:100 (Thermo Fisher Scientific, Temecula, CA), Tbr1 1:500
(Chemicon, Billerica, MA), Tbr2 1:500 (Gift from Dr Hevner,
University of Washington, WA), and NKx2.1 1:250 (Epitomics,
Burlingame, CA).
Primary antibodies were followed by secondary antibodies
(Jackson ImmunoResearch Laboratories, PA) for 1 h and a
short incubation in the nuclear stain bisbenzamide (Sigma).
Coverslips were viewed with the Axioskop microscope (Zeiss,
Germany).Flow cytometric analysis
Flow cytometric analysis was performed by standard staining
procedures on BD-FACS Aria (BD Biosciences, San Jose, CA)
using APC Mouse Anti-Human CD15 (BD Biosciences). Dead
cells were excluded from our analysis by their ability to
incorporate propidium iodide (PI) and background fluores-
cence by using unlabeled cells and isotype controls. Data were
analyzed using FlowJo Software (Tree Star, Inc., Ashland, OR).
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To enrich RG cells for our in vitro studies, we applied a method
based on the expression of LeX carbohydrate epitope (fucose
N-acetyl lactosamine, an extracellular matrix-associated car-
bohydrate also known as LewisX, SSEA-1 or CD15) on the cell
surface (Mo et al., 2007). We first generated dorsal forebrain
progenitor cells from hESCs and then isolated a LeX+ population
of hESC-RG cells using a magnetic cell separation system with
LeX (CD15+) isolation kit (MACS, Miltenyi Biotec, Germany)
according to manufacturer's instructions. Selected cells were
plated onto poly-L-ornithine-laminin-coated 12 mm coverslips
(Carolina Biological Supply, Burlington, NC) and cultured in
either a proliferation medium (DMEM/F12/B27 supplemented
with 20 ng/ml FGF2) or a differentiation medium (DMEM/F12/
B27 supplemented with 10 ng/ml brain derived neurotrophic
factor-BDNF; PeproTech), as indicated. Subsequently, the cells
were immuno-labeled with cell-type specific antibodies, as
described above.
Pax6 loss-of-function experiments
Knockdown of Pax6 was achieved as previously described
for fetal RG cells (Mo and Zecevic, 2008). hESC-RG cells
were electroporated with 5 μg of either interference Pax6
siRNA or scrambled RNA (control) using Amaxa system
(Nucleofection, Lonza, Gaithersburg, MD) according to
manufacturer's instructions.
Proliferation assay
A thymidine analog, bromodeoxyuridine (BrdU, 20 μM, Sigma,
St Louis, MO) that incorporates into DNA of dividing cells
was added to the cell cultures in the proliferation medium for
the last 6 h before fixing and immunostaining as previously
described (Mo et al., 2007).
Cell viability analysis
Ethidiumhomodimer-1 (EthD-1 Live/DeadViability/Cytotoxicity
kit; Invitrogen) was used in co-culture experiments to quantify
cell death as the ratio of EthD-1+ cells to the total cell count.
Patch clamp
Whole-cell patch recordings were performed in the second
week of neurodifferentiation (days 7, 8, and 9) and in the
fourth week (days 21, 22, and 23). Patch clamp equipment,
and physiological solutions were described previously (Belinsky
et al., 2011). Before patching, the GFP-positive cells were
identified by fluorescence; standard Olympus GFP filter cube.
In one set of experiments, rhodamine-dextran 3000 (50 μM)
was added to the intracellular solution. In voltage-clamp
configuration, cells were given a series of voltage steps
(duration, 50 ms) from −90 to +30 mV from a holding po-
tential of −70 mV. In current-clamp configuration, after
determining the actual resting membrane potential, all cells
were first clamped at −60 mV using negative direct current
(range 5–15 pA) and then a series of current steps from −20
to +120 pA was applied to test action potential (AP) firingpattern. Electrical traces were analyzed using Clampfit 9.2
(Molecular Devices). Data are expressed as means ± SEMs.Quantitative real-time PCR analysis
Total RNA was extracted from cells using TRIZOL® reagent
(Invitrogen, Carlsbad, CA) according to the manufacturer's
instructions. Approximately 1 μg of RNAwas used in the reverse
transcription reaction using M-MuLV reverse transcriptase with
random hexamers (Fermentas, Vilnus, Lithuania) according to
the manufacturer's instructions. Real-time PCR was performed
in a Realplex2 Mastercycler (Eppendorf, Hamburg, Germany)
using 96-well reaction plates (Eppendorf, Hamburg, Germany).
The reactions were prepared according to the standard
protocol for one-step QuantiTect SYBR Green RT-PCR (Applied
Biosystems, Cheshire, UK). The sequences 5′ → 3′ of the
forward (F) and reverse (R) primers were as follows:GAPDH: (F) ACCACCATGGAGAAGGC/(R) GGCATGGACTGTG
GTCATGA
Sox1: (F) CAATGCGGGGAGGAGAAGTC/(R) CTCTGGACCAA
ACTGTGGCG
Pax6: (F) AACAGACACAGCCCTCACAAACA/(R) CGGGAACT
TGAACTGGAACTGAC
Otx2: (F) CCACAGCAGAATGGAGGTCA/(R) CTGGGTGGAA
AGAGAAGCTG
Pax7: (F) CCAAGATTCTTTGCCGCTAC/(R) CAGGATGCCGT
CGATGCTGT
HoxC8: (F) TTTATGGGGCTCAGCAAGAGG/(R) TCCACTTCATC
CTTCGGTTCTG
Gsx2: (F) ACTTCGCACCTGCACTCCTC/(R) ACTTCGCAC
CTGCACTCCTC
Nkx2.1: (F) ATTGCTAGCGCCACCATGTCGATGAGTCCAA
AG/(R) TTAGAATTCACCA
GGTCCGACCATA. Olig2: (F) AGTCATCCTCGTCCAGCACC/
(R) TCCATGGCGATGTTGAGGT.
The thermal cycle conditions were 95 °C for 2 min
followed by 40 cycles of 15 s at 95 °C, 15 s at 55 °C and 20 s
at 68 °C. All assays were performed in triplicates. Averaged
cycle of threshold (Ct) values of GAPDH triplicates were
subtracted from Ct values of target genes to obtain ΔCt, and
then relative gene expression was determined as 2−ΔCt. The
results were presented relative to the control value, which
was arbitrarily set to 1.Cell counting and statistical analysis
Cells stained with the nuclear stain bisbenzamide and
various cellular markers were visualized with a Zeiss
Axiovision fluorescence microscope. Before quantification,
10 predesignated, adjacent optical fields of view were se-
lected in each culture and examined at magnification 40×
(one field has a surface area of 0.5 mm2). The percentage
of immunolabeled cells of total bisbenzamide+ (BB) or GFP+
cells was calculated. Data are presented as a mean ± SEM.
Statistical differences between the groups were evaluated
with a Student's t-test for unpaired data; level of significance
was set at p ≤ 0.05.
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Generation of hESC-radial glial cells
To generate RG cells from hESCweused a H9 cell line (passages
30–45) and a protocol from Nat et al. (2007). In our H9 cell
cultures, neural tube-like structures became positive for
Pax6 at 21 DIV (days in vitro) (Figs. 1A, B). After mechanicalisolation and enzymatic dissociation of these neural tube-like
structures, immunocytological analysis revealed the homoge-
neous expression of diagnostic markers of RG cells (Campbell
and Gotz, 2002; Noctor et al., 2001; Mo and Zecevic, 2008,
2009), including nestin, Sox1 (Fig. 1C) and vimentin (Fig. 1D) as
well as the surface marker LeX.
Immunocytochemical analysis of LeX expression in cultures
carried out at 38, 43, and 72 DIV revealed that at 43 DIV the
591Radial glia derived from human-ESCexpression of LeX plateaued (Fig. 1H). Hence all subsequent
experiments were commenced at 43 DIV (Fig. 1A). Flow
cytometric analysis at 43 DIV established that 70 ± 2% of
cultured cells were immunopositive for LeX (Fig. 1I). Prolifer-
ation analysis with Ki67, a nuclear protein expressed in all
phases of the cell cycle, in combination with BrdU, expressed
in the S phase of the cell cycle, revealed that the majority
of cells (92.5 ± 0.3%) were proliferating. Furthermore, one
fourth (25 ± 0.11%) of all Ki67+ cells were in the S phase of the
cell cycle as seen by co-labeling with BrdU (Figs. 1F, G).
To study whether the cells in our cultures belong to the
forebrain, we labeled them with Foxg1, a forebrain transcrip-
tion factor (Tao and Lai, 1992). The expression of Foxg1 was
detected at 21 DIV, 30 DIV and is present in 90% of all cells at
43 DIV, consistent with the time line of Foxg1 expression
previously described by Li et al. (2009).
We found that the initially observed expression of Foxg1 in
radial glia at 43 DIV (Fig. 1D) was maintained after cultures
were kept in the differentiation medium for additional 7 DIV*
(Fig. 1A), when cells differentiated in β-III-tubulin+ young
neurons (Fig. 1E). Moreover, 90% of these cells were positive
for dorsal telencephalic markers such as Pax6 and Tbr2, and
only about 1% expressed ventral marker Nkx2.1 (Supplemental
Fig. 1). The rostro-caudal identity was confirmed by quantita-
tive RT-PCR analysis (qPCR). Figs. 1J, K show the expression of
neuroectodermal marker Sox1, the transcriptional activation
of other forebrain markers such as Otx2, but also Pax7, a dorsal
marker of mesencephalon and spinal cord and thoracic marker
HoxC8. Dorsal–ventral patterning was revealed by a strong
expression of dorsalmarker Pax6, but also two ventralmarkers,
Gsx2 (lateral ganglionic eminence, LGE marker) and Olig2,
whereas Nkx2.1 (marker of themedial GE) was not expressed in
hESC-RG. Olig2 expression in these cells is in agreementwith its
expression in both ventral and dorsal regions of the human fetal
forebrain (Jakovcevski and Zecevic, 2005). Our results demon-
strate the heterogeneity of hESC-RG cell population, with both
ventral and dorsal genes being present.Enrichment of LeX+ cells
Wehave previously reported that RG cells can be enriched from
human fetal brain tissue on the basis of the surface marker LeX
(Mo et al., 2007). Using the same criteria and magnetic cell
separation method (MACS), we isolated and characterized RG
cells produced during in vitro neural differentiation of hESC
(Fig. 2A).
After MAC separation, flow cytometry analysis of the LeX+
cell fraction indicated a purity of 95.5% (Fig. 2G). The MACSFigure 1 Radial glial cells generated from hESC (hESC-RG cell
experiments were performed; 43 DIV was a starting point for further
(B) Neural tube-like structures labeled with Pax6 at 21 DIV. (C) The
well as a forebrain marker Foxg1 in (D) vimentin+ radial glia and in
BrdU and Ki67 at 72 DIV. (G) Histogram showing that the majority o
BrdU+ and Ki67. (H) The percentage of LeX+ cells at three time poin
LeX+ (empty); isotype control antibody was used for background dete
divided by the number of cells in the bin that contains the largest
analysis showing the transcriptional profiling of neural and rostro
CX) and ganglionic eminence (FH-GE) were used as a positive cont
cells. BB—bisbenzamide stained cell nuclei. BrdU/Ki67—cells in ph
Ki67/BB—Ki67+ calculated as a percentage from all cells labeled withenriched LeX+ cells were plated under adherent conditions
and 24 h later these cells had bipolar morphology of RG cells
(Fig. 2A). Antigen characteristics of these cells confirmed
their astroglia (GFAP, vimentin) and stem/progenitor fate
(nestin, Pax6). The immunostaining experiments have shown
that RG-like cells co-expressed the intermediate filament
protein nestin, reported in mitotic RG cells (Hockfield and
McKay, 1985; Noctor et al., 2001) and the astroglia marker
GFAP (Figs. 2B–D). After 2 DIV* (Fig. 1A) in the proliferation
medium, the cells could be double labeled with a marker of
dividing RG cells (phosphorylated vimentin, antibody 4A4) and
GFAP (Figs. 2E–F), Pax6 and GFAP (Figs. 2I–J), and vimentin
(Fig. 2H). Overall these findings indicate that hESC-RG cells
exhibit the same astroglia and stem/progenitor markers as RG
cells isolated from human fetal tissue (Zecevic, 2004; Howard
et al., 2006; Mo et al., 2007).Proliferation and differentiation of hESC-RG cells
in vitro
To evaluate the proliferative ability of hESC-RG cells, we added
BrdU to cultures after LeX MAC sorting isolation. Immunostain-
ing after 2 DIV* in the proliferation medium demonstrated that
14.7% (118/803) of the LeX+ cells incorporated BrdU (Fig. 3A).
Within the BrdU+ cells, 9.3% (3/32) were co-labeled with
β-III-tubulin and 7.1% (3/42) with DCX (doublecortin),
suggesting the presence of neuron-restricted-progenitors.
To assess the differentiation potential of hESC-RG cells, we
cultured them in the differentiationmedium for 7 DIV* (Fig. 1A)
and applied cell-type specific markers. hESC-RG cells changed
their morphology to more mature cell types, and differentiated
predominantly (93 ± 1.5%) into GFAP+ cells (Figs. 3B–C), far less
(7 ± 0.3%) into neurons labeled by immature neuron markers,
βIII-tubulin (Figs. 3C–G) or the microtubule-associated pro-
teins, DCX (Fig. 3D) and MAP2 (Fig. 3E). Few cells were
immunolabeled with PDGFRα, a marker for immature oligo-
dendrocyte progenitors (Fig. 3F). These results indicated that
hESC-RG cells maintained pluripotency, differentiating mainly
into astroglia and less often into neurons or oligodendrocytes,
similar to reports on human fetal RG (Mo et al., 2007; Mo and
Zecevic, 2008, 2009).The role of transcription factor Pax6
Pax6 transcription factor (Pair Box 6) promotes the neurogenic
fate of RG cells both in rodents (Götz et al., 1998) and in
human fetal cortical cultures (Mo and Zecevic, 2008). Here wes). (A) Experimental design of the time points at which the
experiments that were done at 2 DIV*, 7 DIV*, 21 DIV* after that.
se cells express neural progenitor markers, Sox1 and Nestin, as
(E) β-III-tubulin+ young neurons. (F) Cell proliferation seen with
f cells at 72 DIV were labeled with Ki67 whereas 25% were both
ts in culture. (I) Flow cytometry analysis: majority of cells were
rmination (solid). The % of Max is the number of cells in each bin
number of cells (FlowJo software). (J,K) Quantitative RT-PCR
-caudal markers at 21 DIV. Fetal human cerebral cortex (FH-
rol. Insets provide higher magnification of the double-labeled
ase S calculated as a percentage of BrdU+ from all Ki67+ cells.
nuclear stain (BB). Scale bars: 50 μm, 10 μm (inset).
Figure 2 Characterization of hESC-RG cells isolated by magnetic activated cell separation system (MACS). (A) On adherent
conditions the cells have bipolar morphology with long processes. (B–F) Cells co-labeled with nestin (B), GFAP (C), merged image (D)
phosphorylated vimentin (4A4 antibody) (E) and GFAP (F). (G)The purity of LeX+ cells after MACS isolation in the stained sample (solid)
vs the unstained sample (empty) demonstrates that LeX+ cells represent the majority of purified cells. (H–J) Bipolar cells express
radial glial markers: vimentin (H), and co-labeled with GFAP (I) and Pax6 (J) (arrows indicate double-labeled cells). Nuclei were
stained with bisbenzamide (blue). Scale bars: 50 μm, 10 μm.
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of hESC-RG by knocking down Pax6 expression.
Progeny of hESC-RG transfected with either interference
siRNA Pax6 or control, scrambled RNA (cRNA) was compared.
Three days after transfection with siRNA, Pax6 protein was not
detected in hESC-RG cells (Supplemental Fig. 2), whereas
vimentin expression was unaffected (data not shown). Control
transfected cells kept their Pax6 expression (Supplemental
Fig. 2). These results indicate successful knock-down of Pax6
gene in siRNA Pax6 transfected cells that retained their RG
identity. Next, we studied the effect of Pax6 on proliferation
of hESC-RG as demonstrated with Ki67 labeling. The prolifer-
ation rate of cells transfected with siRNA Pax6 was reduced by
a factor of 3 (25 ± 10%) compared to control transfected cells
(75 ± 13%). This indicates that knocking down Pax6 reduces
the proliferation capacity of hESC-RG cells.
We further investigated the role of Pax6 in hESC-RG cell fate
determination after culturing transfected cells for 7 DIV* in the
differentiation medium. The number of Pax6 knock-down cells
(15.5%; 11/71) that differentiated into neurons co-labeledwith
β-III-tubulin was half of that in control transfected cells (34.4%;
21/16). In contrast, the number of GFAP co-labeled cells was
81.4% (22/27) in Pax-6 knockdown cells versus 53.5% (15/28) incontrol transfected cells. Since transfection efficiency is
around 10%, these numbers are not absolute values but
rather estimates which illustrate the ratio between neurons
and astroglia generated from transfected cells. Overall, these
results are similar to the ones reported for human fetal RG (Mo
and Zecevic, 2008) and support the idea that Pax6 regulates
the proliferation and neurogenic fate of hESC-RG cells in a
similar manner.The effect of the microenvironment on hESC-RG fate
The effect of the microenvironment on the neurogenic
properties of hESC-RG was examined by co-culturing LeX+
hESC-RG on fetal human brain cells. Fetal brain cultures were
made from two different forebrains at mid-gestation (17 and
22 gw) obtained from the Brain Bank repositories. Similar human
fetal cultures at mid-gestation were described in more detail in
our previous reports (Howard et al., 2006; Zecevic et al., 2005;
Mo et al., 2007). After 7 DIV two cell types, neurons and
astroglia, can be recognized based on immunomarkers in these
cultures. GFAP+ cells accounted for 45 ± 4.4% and β-III-tubulin+
neurons for 52 ± 3% of total cells (Supplemental Fig. 3).
Figure 3 Sorted hESC-RG cells are multipotent in vitro. (A) BrdU incorporation after 2 DIV* in the proliferation medium. (B–F) In
the differentiation medium hESC-RG cells generate mainly mature-looking GFAP+ astrocytes (B), neurons labeled with β-III-tubulin
(C), DCX+ (D) or MAP2 antibody (E), and rarely PDGFR-α+ oligodendrocyte progenitors (F). (G) Quantification of hESC-RG progeny after
7 DIV* in the differentiation medium. Data represent three independent experiments. ⁎⁎⁎p b 0.0001. Nuclei were stained with
bisbenzamide (blue). Scale bars: 50 μm, 10 μm.
593Radial glia derived from human-ESCIn co-culture system we used stably transfected hESC with
robust levels of EGFP (enhanced green fluorescent protein),
which permitted their identification after plating on human
fetal cells. Similar to previous experiments, MACS was used
to enrich green GFP+ hESC-RG before plating them over either
human fetal brain cultures or on poly-L-ornithine-laminin
(control cultures).
First, we measured the proliferation rate of GFP+ hESC-RG
cells co-cultured with human fetal cells in the proliferation
medium. After 2 DIV*, the proliferative marker Ki67 was de-
tected in 24% of all GFP+ cells (64 out of 271). To assess
differentiation of GFP+ hESC-RG, both control cultures (GFP+
hESC-RG cultured on poly-L-ornithine-laminin) and co-cultures
were kept in the differentiation medium for 7 DIV*, fixed,
and double-labeled with cell-type specific markers, GFAP,
β-III-tubulin or MAP2 (Fig. 4). In the co-cultures, themajority of
cells differentiated into β-III-tubulin+ (79 ± 2.5%) and MAP2+
(80 ± 3.1%) neurons (Fig. 4). Only 14 ± 2.2% of GFP+ hESC-RG
cells differentiated into GFAP+ cells (Figs. 4B, F, I). In contrast
to this, in control cultures the number of β-III-tubulin+ neurons
was 9.0 ± 1% and GFAP+ cells 87.0 ± 2.2% (Fig. 4I) similar to
results obtained earlier.
Hence, in the presence of the same differentiationmedium,
the number of neurons derived from GFP+ hESC-RG had in-
creased by a factor of 9 in co-cultures with human fetal
forebrain cells, whereas the number of GFAP+ astroglia de-
creased by a factor of more than 6 in comparison to control
cultures kept on poly-L-ornithine-laminin.
The obvious question is whether the above mentioned
neurogenic effect is due to cell–cell interaction, agents
secreted in the cultures, or both. We thus investigated thedifferentiation fate of GFP+ hESC-RG cells in conditioned
medium (CM) from human fetal cells. After 7 DIV* in CM, GFP+
hESC-RG cells generated significantly more β-III-tubulin+ cells
(52 ± 2.5% vs. 9 ± 1%) and fewer GFAP+ cells (28 ± 2.7% vs.
87 ± 2.2%) than those treated with the standard differentia-
tion medium (control) (Fig. 4J). Thus, soluble factors from
human fetal brain cell cultures are capable of promoting
neuronal cell fate of GFP+ hESC-RG cells. However, the
neuron/glia ratio in CM alone was 1.67 compared to 5.33 in
co-culture conditions (Fig. 4K). Hence, although CM pro-
motes neurogenesis compared to the control medium, the
combined effect of cell–cell interaction and soluble factors,
was significantly more powerful than the effect of soluble
factors alone (Fig. 4K).
Next, we tested whether specific neuronal sub-types can
be generated from green GFP+ hESC-RG in co-cultures. The
predominant neuronal cell type generated fromGFP+ hESC-RG
was pyramidal glutaminergic neurons labeled with SMI-32 (55 ±
7.2%) and Tbr1 (40 ± 4.4%), and fewer cells were positive for
interneuron markers GABA (17 ± 4%), calretinin (3.5 ± 1.5%),
and TH+ (tyrosine hydroxylase) dopaminergic neurons (15.4 ±
2.3%) (Fig. 5). By 21 DIV* (Fig. 1A), the beginning of syn-
aptogenesis was indicated by the expression of the synaptic
vesicle protein 2 (SV2) in some presynaptic terminals (Fig. 5F).
Cell culture viability was validated with the EthD-1kit
(Invitrogen). After 7 DIV*, a relatively low cell death rate of
7.5 ± 0.84% was observed (Supplemental Fig. 4). Moreover,
5.5% (21 out of 380 GFP+ cells) were still proliferating (Ki67+).
The remaining cells had exited the cell cycle and differenti-
ated as confirmedby a lack of nestin (immature neural protein)
labeling.
Figure 4 Co-culture experiments with GFP+ hESC-RG and human fetal brain cells. GFP+ hESC-RG cells differentiated into neurons
co-labeled with β-III-tubulin (A) and astroglia cells co-labeled with GFAP (arrows) (B). Higher magnification of GFP+ hESC-RG cells
co-labeled with neuronal marker MAP2 (C–E, arrows) or GFAP (F–H, arrows). (I) Quantification shows that more neurons than
astroglia are produced from GFP+ hESC-RG cells in the co-culture and treated with conditioned medium (CM). In co-culture, the
number of immune-labeled cells is calculated as a percentage of GFP+ cells, whereas in CM and control as a percentage from all cells
in the culture. Data represent three independent experiments. ⁎⁎⁎p b 0.0001. Scale bars: 50 μm, 10 μm.
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Neuronal fate of GFP-hESC-RG was not based only on
immunocytochemistry with class specific markers, but also
on their physiological properties. Individual neurons wereselected for patching by alternating between fluorescence
(Fig. 6A1) and infrared (Fig. 6A2) video microscopy. The cell
bodies of GFP+ cells were bright, but their thin neuronal
processes were not satisfactorily resolved (Fig. 6A1). Ten
neurons were injectedwith rhodamine via the recording patch
Figure 5 Differentiation of various neuronal cell types from GFP+ hESC-RG in co-cultures after 7 DIV*. Co-expression of GFP and the
interneuronal markers, GABA (A), calretinin-CalR (B), dopaminergic marker tyrosine hydroxylase (TH) (C), pyramidal cell markers
SMI-32 (D) and Tbr1 (E). Arrows in A–E point to co-labeled cells. (F) Synaptic vesicle labeled with SV2 antibody at 21 DIV (arrows).
(G) Percentages of cell-type specific cells. Scale bar: 10 μm.
595Radial glia derived from human-ESCpipette revealing elaborate axo-dendritic trees consisting of
primary, secondary, and tertiary branches (Fig. 6A3). In some
cases, thin axon collaterals were documented branching
at 90° (Fig. 6A3, arrows). Patch electrode recordings were
made on days 7, 8, and 9 (Week-2) and days 21, 22, and 23
(Week-4) after the initial seeding on human fetal mix cell
culture of GFP-hESC-RG cells isolated at 43 DIV. The average
resting membrane potential from days 7/8/9 to 21/22/23 were−21.9, −29.0, −20.0 mV and −25.0 mV, −26.8, −34.9 mV,
respectively. The sodium current amplitude almost doubled as
GFP+ neurons transitioned from the 2nd to the 4th differenti-
ation week (Fig. 6B1). In response to a depolarizing current, the
GFP+ neurons generated 5 types of voltagewaveforms (Fig. 6C2,
AP firing pattern). Cells with a passive electrical response
(unable to generate AP) were only found in the 2nd week of
neuro-differentiation (Fig. 6C1, Week-2, white bars). Voltage
Figure 6 Physiological properties of cells derived from hESC-RG. A1) GFP
+ hESC-RG viewed on the electrophysiology station using
green fluorescence channel. Scale, 20 μm. A2) Same cells as in A1 viewed using infrared DIC video microscopy. “Patch” marks the
contours of a patch electrode used for recordings and injection of red fluorescent dye rhodamine. A3) Only the injected cell is visible
in red channel. Arrows indicate axon collateral branch points. B1) Average peak sodium current on six recording days. B2)
Representative membrane currents in response to voltage steps from −90 to +30 mV, obtained in the second (Week-2) and fourth
weeks (Week-4) of neurodifferentiation. C1) All cells in the present study (n = 38) aligned according to the order of patching, from
left to right. Each bar corresponds to one cell. The height of the bar indicates the category of AP firing pattern. C2) Representative
voltage waveforms in response to a 1 s-long depolarizing current pulse.
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597Radial glia derived from human-ESCwaveforms representative of mature neurons (Repetitive-2)
were only encountered in the 4th week of neuro-differentiation
(Week-4). Neurons are the only cell type in the brain endowed
with a fast sodium current and ability to generate regenerative
spikes. Human postmitotic neurons begin to generate nonlinear
voltage waveforms (abortive spikes, Fig. 6C2) when their peak
sodium current exceeds 200 pA (Moore et al., 2009). Sodium
current greater than 200 pA was found in 8 out of 19 neurons
tested in Week-2; and in 18 out of 19 neurons tested in
Week-4. The electrophysiological recordings of transmem-
brane currents (Fig. 6B2) and depolarization-induced voltage
waveforms (Fig. 6C2), together with elaborate axo-dendritic
trees (Fig. 6A3), clearly indicate that hESC-RG gave rise to a
neuronal lineage.
Combined results from molecular and physiological mea-
surements (Figs. 1–6) demonstrate that the human fetal brain
microenvironment was efficient in promoting neurogenic fate
over gliogenic fate of the hESC-RG cells.Discussion
The main findings of this study are that hESC-derived RG
cells share numerous properties with human fetal RG cells.
Neurogenic fate of these cells is promoted by transcription
factor Pax6 as well as by the microenvironment of human
fetal brain.
This is important since unlike human fetal brain tissue,
the hESC-RG cells are easily accessible, can be standardized
and applied in research related to human brain development
and neural tissue repair.
RG cells can be isolated and expanded from mouse and
human-derived ES cells or fetal brain and adult subventricular
zone (SVZ) (Gregg and Weiss, 2003; Conti et al., 2005; Glaser
and Brustle, 2005; Pollard et al., 2006; Pollard and Conti,
2007). However, RG cells from different species can display
different properties (Conti et al., 2005; Hansen et al., 2010).
For example, whereas, GFAP is expressed early in the human
RG-like cells, it is undetectable in mouse-derived RG-like cells
in vitro. Thus, it is necessary to characterize RG cells derived
from hESC.
In our earlier work (Mo et al., 2007) the surface marker
LeX has been used to enrich human fetal RG cells in vitro. In
the present study, we found that the same marker can be
successfully used to isolate hESC-RG cells. Moreover, these
cells are similar to the fetal cortical RG cells in their antigen
characteristics, as well as their proliferation and differen-
tiation potentials. Although not all hESC-RG express the LeX
antigen, all LeX+ cells were found to express the RG markers
(Fig. 1). This is consistent with the heterogeneity of the
antigenic characteristics of RG in rodents (Hartfuss et al.,
2001; Malatesta et al., 2003) and human fetal brain (Howard
et al., 2006). Their differentiation into Foxg1+ forebrain
cells was similar to previous reports that in the absence of
known morphogens, hESC differentiate into cells with dorsal
telencephalic characteristics (Li et al., 2009).
LeX+-RG cells generated from hESC are mitotically active
progenitors, with astroglial and stem cell/progenitor charac-
teristics. They are also multipotent cells that can differentiate
into all three neural lineages: astrocytes, neurons and oligo-
dendrocytes. In these aspects, hESC-RG cells are similar to what
has been reported for RG cells in the mouse (Abramova et al.,2005; Capela and Temple, 2006; Liour et al., 2006) and in the
human fetal brain (Mo et al., 2007; Mo and Zecevic, 2008,
2009).
Several lines of evidence suggest that Pax6 transcription
factor promotes the neurogenic fate of RG cells in rodents
(Götz et al., 1998). Most of the pyramidal neurons in the
developing telencephalon are derived from Pax6 positive RG
cells (Malatesta et al., 2003). Forced expression of Pax6 in
rodent astrocytes is sufficient to drive neurogenesis in these
cells (Heins et al., 2002). Moreover, Pax6 is necessary and
sufficient for neuroepithelial differentiation from hESC (Zhang
et al., 2010). We now demonstrate that transcription factor
Pax6 influences proliferation and the number of neurons gen-
erated from hESC-RG cells.
This finding is consistent with our observations in human
fetal RG cells (Mo and Zecevic, 2008), indicating that in both
cell populations Pax6 affects proliferation as well as neuronal
fate.
Numerous studies have reported the successful trans-
plantation of hESC into rodent brains (Kelly et al., 2004; Roy
et al., 2006; Yang et al., 2008). However, far less is known
about how hESC behave when transplanted into the human
brain (Lindvall and Kokaia, 2006). This knowledge, however,
is very important for the development of future therapies.
In the present study, we created a co-culture system in an
attempt tomimic the cellular interactions thatmay occur upon
transplantation of hESC-RG cells in the human fetal forebrain.
Our experiments demonstrated that the microenvironment of
the human fetal forebrain (17–22 gw) promotes neurogenesis
in hESC-RG cells when compared to the commonly-used
substrate, poly-L-ornithine-laminin (control). In the presence
of the same differentiation medium, the number of neurons
derived from hESC-RG cells was nine fold higher in co-cultures
compared to the control cultures. At the same time the
number of derived astroglia decreased more than six fold
compared to control cultures. This is in line with our previous
report that RG isolated from mid-gestational human fetal
forebrain generate more neurons than glia (Mo et al., 2007).
Neuronal fate of co-cultured hESC-RG was determined by
general neuronal markers, such as βIII-tubulin and MAP2.
Notably, these cells were functionally evaluated by patch-
clamp recordings. Three lines of evidence strongly indicate
that cells derived from hESC-RG are committed to the
neuronal fate. First, these cells exhibited typical neuronal
morphologies (Fig. 6A3). Second, the peak sodium current
exceeded 200 pA (Fig. 6B2) (Moore et al., 2009). Third, upon
depolarization, the GFP+ cells produced regenerative spikes
(abortive AP, full-size AP, and repetitive APs, Fig. 6C2). With
each day of in vitro cultivation, the two parameters (sodium
current and AP firing pattern) clearly shifted towards values
characteristic of more mature neurons (Figs. 6B1C1).
Mature forebrain neurons can be separated between GABA-
ergic inhibitory and non-GABA-ergic neuron types solely based
on their characteristic action potential firing pattern (Connors
and Gutnick, 1990). In immature human neurons (4 weeks in
vitro), such separation is considerably less reliable because the
sodium and potassium channels are not fully expressed in the
plasma membrane (Moore et al., 2009; Belinsky et al., 2011).
As a consequence of low channel density the AP amplitudes
do not overshoot in repetitive firing (Fig. 6C2, Repetitive-1
and Repetitive-2). We think that voltage waveforms termed
“Single AP” and “Repetitive-2” (Fig. 6C2) pertain to young
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AP-firing pattern (Repetitive-1) is more indicative of immature
fast-spiking GABA-ergic interneurons (Gupta et al., 2000).
Significantly, various neuronal subtypes were generated
from hESC-RG in our co-culture system. More than half of
the generated neurons by their molecular markers were
projection, pyramidal neurons (SMI-32+ and Tbr1+),
but other subtypes, such as interneurons (GABA+ and
calretinin+) and dopaminergic neurons (TH+) were also
derived from hESC-RG under these conditions. Based on the
expression of various patterning markers, such as rostral
and dorsal forebrain markers (Foxg1, Otx2, Pax6 and Tbr2),
but also caudal and ventral markers (Pax7 and HoxC8)
(Figs. 1J, K), the hESC-RG cell population is likely a mixed
population of both dorsal and ventral progenitors. This is
further confirmed by their differentiation into various
neuronal cell types of either dorsal (SMI-32, Tbr1) or
ventral (TH, GABA, calretinin) origin (Fig. 5).
In our hESC-RG cultures, the observed increase in neuro-
genesis was, at least partially, due to secreted factors,
because the neurogenic effect was produced with the
medium conditioned with the human fetal forebrain alone.
The major difference between media collected from control
cultures (grown on poly-L-ornithine-laminin) and CM from
co-cultures, is the presence of astrocytes and neurons in
co-cultures; both cell types can release factors, including
growth factors and cytokines, that may have a role in the
observed increase in the neurogenic fate of GFP hESC-RG.
This is in accord with previous reports, that astrocytes
influence both proliferation and differentiation of embryonic
and adult neural stem cells, and specifically promote neuro-
genic fate of neural stem cells (Roy et al., 2006; Nakayama et
al., 2003; Song et al., 2002). Factors that affect neural stem
cells range from bone morphogenetic protein (BMPs) (Li et al.,
1998), Wnt signaling (Muroyama et al., 2004; Li et al., 2009), to
Sonic Hedgehog (Shh) and ciliary neurotrophic factor (CNTF)
(Zhu et al., 1999). Not only astrocytes, but also neurons release
factors, such as BMPs, that promote neurogenesis from stem
cells (Chang et al., 2003). In addition, inhibition of Notch
signaling by the γ-secretase inhibitor increases neurogenesis of
cultured hESC (Borghese et al., 2010). One cannot, however,
exclude the contribution of the regulatory signals provided by
cell extracellular matrix (ECM) interaction during this process.
Poly-L-ornithine is a non-ECM positively charged polymer,
whereas laminin is a component of the ECM which is expressed
in the human cortex during developmental stages (Anlar et al.,
2002; Flanagan et al., 2006). Laminin/integrin signaling is very
important for ECM–cell interactions regulating the fate of
neural progenitors (Flanagan et al., 2006; Tate et al., 2004;
Ma et al., 2008). Thus, the effect of the entire ECM on the
progenitors needs to be taken into account, since they can
influence each other and consequently change the final
outcome.
The finding that co-culturing hESC-RG with the human fetal
brain tissue or with conditioned media can accelerate produc-
tion of specific neuronal subtypes, might have relevance for
development of cell-replacement therapies for various neuro-
logical disorders from Parkinson's, Huntington's to Alzheimer's
disease (Lindvall and Kokaia, 2006, 2009).
In Parkinson's disease, a progressive loss of dopaminergic
(DA) neurons occurs and transplantation of fetal derived DA
neurons has shown some promise, but the use of human stemcells has yet to be accomplished (Lindvall and Kokaia, 2006,
2009; Politis and Lindvall, 2012). Particularly, a recent study
showed that radial glial cells are the neural progenitors of
DA neurons in the human ventral midbrain (Hebsgaard et al.,
2009).
In summary, we compared fetal human RG cells and
radial glial cells generated by hESC and concluded that
these two cell populations share numerous antigen charac-
teristics as well as proliferative capacity and differentia-
tion pattern.
Transcription factor Pax6 influences their neurogenic
capability, whereas, the environment of the human fetal
forebrain significantly increases the genesis of several neuronal
sub-types fromhESC-RG cells. These findingsmay have practical
implications in research related to human brain development
and to cell replacement therapies for neurological disorders,
where it is necessary to generate a sufficient number of
neurons.
Supplementary data to this article can be found online at
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